Shorter Steroid Courses Hold Promise in Autoimmune Vasculitis (CME/CE)

(MedPage Today) -- Study had similar rates of primary endpoint success as RAVE trial
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news